Traditional Electrosurgery System Versus Low Thermal Tissue Dissection System for Total Mastectomy

May 24, 2017 updated by: Suebwong Chuthapisth, Mahidol University

"Comparison of Traditional Electrosurgery System Versus Low Thermal Tissue Dissection System for Total Mastectomy: A Prospective Randomized Controlled Trial"

Breast cancer is one of the most common cancer among women nowadays. There are lots of modality of treatment and one of them is Mastectomy. We found out that seroma is one of the disturbing postoperative complications after mastectomy. In our study we want to compare the outcome between using the conventional electrocautery and the low thermal tissue dissection. We expected that the serum production should be lower in cases using low thermal system electrosurgery system.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bangkok, Thailand
        • Recruiting
        • Faculty of Medicine, Siriraj Hospital
        • Contact:
          • Piratthima Vachiraprakarnsakul
          • Phone Number: +66830693791
        • Principal Investigator:
          • Piratthima Vachiraprakarnsakul, M.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female aged >18 years old
  • Patients that fulfill the indication of mastectomy
  • Medium-sized breast volume (Breast weight < 1500 grams)

Exclusion Criteria:

  • Patients who cannot complete the informed consent
  • Patients with ASA CLASS > 3

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DEVICE_FEASIBILITY
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Conventional electrocautery
Conventional Electrocautery
EXPERIMENTAL: Low thermal electrosurgery system
PEAK Plasmablade

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drainage volume after surgery
Time Frame: Up to 24 weeks
Drainage volume detected after surgery which is measured in drainage container and measured by syringe gauge aspiration
Up to 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative Pain
Time Frame: Up to 24 weeks
Post-operative Pain measured using 0-10 Numeric pain scale
Up to 24 weeks
Patient's Hospital costs
Time Frame: up to 1 week
Expenses that the patient has to pay while staying in the hospital
up to 1 week
Wound infection
Time Frame: Up to 24 weeks
Wound infection after surgery
Up to 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2017

Primary Completion (ANTICIPATED)

March 25, 2018

Study Completion (ANTICIPATED)

October 30, 2018

Study Registration Dates

First Submitted

May 23, 2017

First Submitted That Met QC Criteria

May 24, 2017

First Posted (ACTUAL)

May 30, 2017

Study Record Updates

Last Update Posted (ACTUAL)

May 30, 2017

Last Update Submitted That Met QC Criteria

May 24, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • convplas

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Seroma

Clinical Trials on Conventional Electrocautery

Subscribe